183 related articles for article (PubMed ID: 27540967)
1. Effectiveness of Exercise- and Cognitive-Based Treatments on Salivary Cortisol Levels and Sundowning Syndrome Symptoms in Patients with Alzheimer's Disease.
Venturelli M; Sollima A; Cè E; Limonta E; Bisconti AV; Brasioli A; Muti E; Esposito F
J Alzheimers Dis; 2016 Jul; 53(4):1631-40. PubMed ID: 27540967
[TBL] [Abstract][Full Text] [Related]
2. The effect of therapeutic touch on agitated behavior and cortisol in persons with Alzheimer's disease.
Woods DL; Dimond M
Biol Res Nurs; 2002 Oct; 4(2):104-14. PubMed ID: 12408216
[TBL] [Abstract][Full Text] [Related]
3. Altered circadian cortisol secretion in Alzheimer's disease: clinical and neuroradiological aspects.
Giubilei F; Patacchioli FR; Antonini G; Sepe Monti M; Tisei P; Bastianello S; Monnazzi P; Angelucci L
J Neurosci Res; 2001 Oct; 66(2):262-5. PubMed ID: 11592122
[TBL] [Abstract][Full Text] [Related]
4. Changes in salivary cortisol and corticosteroid receptor-alpha mRNA expression following a 3-week multidisciplinary treatment program in patients with fibromyalgia.
Bonifazi M; Suman AL; Cambiaggi C; Felici A; Grasso G; Lodi L; Mencarelli M; Muscettola M; Carli G
Psychoneuroendocrinology; 2006 Oct; 31(9):1076-86. PubMed ID: 16962248
[TBL] [Abstract][Full Text] [Related]
5. Slowing the progression of cognitive decline in Alzheimer's disease using mifepristone.
Belanoff JK; Jurik J; Schatzberg LD; DeBattista C; Schatzberg AF
J Mol Neurosci; 2002; 19(1-2):201-6. PubMed ID: 12212781
[TBL] [Abstract][Full Text] [Related]
6. Change in Fitness and the Relation to Change in Cognition and Neuropsychiatric Symptoms After Aerobic Exercise in Patients with Mild Alzheimer's Disease.
Sobol NA; Dall CH; Høgh P; Hoffmann K; Frederiksen KS; Vogel A; Siersma V; Waldemar G; Hasselbalch SG; Beyer N
J Alzheimers Dis; 2018; 65(1):137-145. PubMed ID: 30040719
[TBL] [Abstract][Full Text] [Related]
7. Effects of high-frequency cranial electrostimulation on the rest-activity rhythm and salivary cortisol in Alzheimer's disease: a pilot study.
Scherder E; Knol D; van Tol MJ; van Someren E; Deijen JB; Swaab D; Scheltens P
Dement Geriatr Cogn Disord; 2006; 22(4):267-72. PubMed ID: 16912480
[TBL] [Abstract][Full Text] [Related]
8. Cognitive performance in patients with burnout, in relation to diurnal salivary cortisol.
Osterberg K; Karlson B; Hansen AM
Stress; 2009 Jan; 12(1):70-81. PubMed ID: 18951245
[TBL] [Abstract][Full Text] [Related]
9. Psychoneuroendocrine effects of cognitive-behavioral stress management in a naturalistic setting--a randomized controlled trial.
Gaab J; Sonderegger L; Scherrer S; Ehlert U
Psychoneuroendocrinology; 2006 May; 31(4):428-38. PubMed ID: 16330155
[TBL] [Abstract][Full Text] [Related]
10. Effect of combined cognitive-behavioural therapy and endurance training on cortisol and salivary alpha-amylase in panic disorder.
Plag J; Gaudlitz K; Schumacher S; Dimeo F; Bobbert T; Kirschbaum C; Ströhle A
J Psychiatr Res; 2014 Nov; 58():12-9. PubMed ID: 25085607
[TBL] [Abstract][Full Text] [Related]
11. The effect of psychotherapy added to pharmacotherapy on cortisol responses in outpatients with major depressive disorder.
Yang TT; Hsiao FH; Wang KC; Ng SM; Ho RT; Chan CL; Lai YM; Chen YT
J Nerv Ment Dis; 2009 Jun; 197(6):401-6. PubMed ID: 19525739
[TBL] [Abstract][Full Text] [Related]
12. Salivary cortisol levels are elevated in the afternoon and at bedtime in children with prenatal alcohol exposure.
Keiver K; Bertram CP; Orr AP; Clarren S
Alcohol; 2015 Feb; 49(1):79-87. PubMed ID: 25583378
[TBL] [Abstract][Full Text] [Related]
13. Effect of cortisol levels on working memory performance in elderly subjects with Alzheimer's disease.
Souza-Talarico JN; Caramelli P; Nitrini R; Chaves EC
Arq Neuropsiquiatr; 2008 Sep; 66(3B):619-24. PubMed ID: 18949251
[TBL] [Abstract][Full Text] [Related]
14. Relationship between cortisol levels and memory performance may be modulated by the presence or absence of cognitive impairment: evidence from healthy elderly, mild cognitive impairment and Alzheimer's disease subjects.
Souza-Talarico JN; Chaves EC; Lupien SJ; Nitrini R; Caramelli P
J Alzheimers Dis; 2010; 19(3):839-48. PubMed ID: 20157240
[TBL] [Abstract][Full Text] [Related]
15. Long-term effects of rivastigmine treatment on neuropsychiatric and behavioral disturbances in nursing home residents with moderate to severe Alzheimer's disease: results of a 52-week open-label study.
Aupperle PM; Koumaras B; Chen M; Rabinowicz A; Mirski D
Curr Med Res Opin; 2004 Oct; 20(10):1605-12. PubMed ID: 15462693
[TBL] [Abstract][Full Text] [Related]
16. Salivary cortisol day profiles in elderly with mild cognitive impairment.
Wolf OT; Convit A; Thorn E; de Leon MJ
Psychoneuroendocrinology; 2002 Oct; 27(7):777-89. PubMed ID: 12183214
[TBL] [Abstract][Full Text] [Related]
17. Elevated basal cortisol level predicts lower hippocampal volume and cognitive decline in Alzheimer's disease.
Huang CW; Lui CC; Chang WN; Lu CH; Wang YL; Chang CC
J Clin Neurosci; 2009 Oct; 16(10):1283-6. PubMed ID: 19570680
[TBL] [Abstract][Full Text] [Related]
18. BDNF, interleukin-6, and salivary cortisol levels in depressed patients treated with desvenlafaxine.
Ninan PT; Shelton RC; Bao W; Guico-Pabia CJ
Prog Neuropsychopharmacol Biol Psychiatry; 2014 Jan; 48():86-91. PubMed ID: 24096053
[TBL] [Abstract][Full Text] [Related]
19. Salivary cortisol determined by enzyme immunoassay is preferable to serum total cortisol for assessment of dynamic hypothalamic--pituitary--adrenal axis activity.
Gozansky WS; Lynn JS; Laudenslager ML; Kohrt WM
Clin Endocrinol (Oxf); 2005 Sep; 63(3):336-41. PubMed ID: 16117823
[TBL] [Abstract][Full Text] [Related]
20. Cognitive-behavioural group therapy improves a psychophysiological marker of stress in caregivers of patients with Alzheimer's disease.
Aboulafia-Brakha T; Suchecki D; Gouveia-Paulino F; Nitrini R; Ptak R
Aging Ment Health; 2014; 18(6):801-8. PubMed ID: 24499394
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
